BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10843293)

  • 21. Hyaline-vascular variant of Castleman's disease mimicking a gastric submucosal tumor.
    Chou SP; Chen LK; Lo SS; Li AF; Chang FC; Hwang SJ
    J Chin Med Assoc; 2004 Mar; 67(3):152-5. PubMed ID: 15181970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of vascular neoplasia in Castleman's disease. Report of seven cases.
    Gerald W; Kostianovsky M; Rosai J
    Am J Surg Pathol; 1990 Jul; 14(7):603-14. PubMed ID: 2356921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
    Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
    Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary hyaline vascular Castleman disease of the kidney: case report and literature review.
    Li Y; Zhao H; Su B; Yang C; Li S; Fu W
    Diagn Pathol; 2019 Aug; 14(1):94. PubMed ID: 31439011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment.
    Wang J; Wang X; Xu J; Song P
    An Bras Dermatol; 2019; 94(5):578-581. PubMed ID: 31777359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease.
    Chang KC; Wang YC; Hung LY; Huang WT; Tsou JH; M Jones D; Song HL; Yeh YM; Kao LY; Medeiros LJ
    Mod Pathol; 2014 Jun; 27(6):823-31. PubMed ID: 24201121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.
    Gould SJ; Diss T; Isaacson PG
    Histopathology; 1990 Aug; 17(2):135-40. PubMed ID: 2227838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration findings in Castleman's disease.
    Meyer L; Gibbons D; Ashfaq R; Vuitch F; Saboorian MH
    Diagn Cytopathol; 1999 Jul; 21(1):57-60. PubMed ID: 10405812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells.
    Ruco LP; Gearing AJ; Pigott R; Pomponi D; Burgio VL; Cafolla A; Baiocchini A; Baroni CD
    Histopathology; 1991 Dec; 19(6):523-8. PubMed ID: 1723957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Serizawa H; Abe K; Mikata A; Toyama K
    Am J Clin Pathol; 1994 Mar; 101(3):290-5. PubMed ID: 8135184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J; Maruyama I
    Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Castleman's disease of the neck.
    Chen CC; Jiang RS; Chou G; Wang CP
    J Chin Med Assoc; 2007 Dec; 70(12):556-8. PubMed ID: 18194898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: The stroma-rich variant of Castleman's disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node.
    Shi X; Liao M; Yin X; Chen Y; Huang C; Yin W; Li J
    Front Oncol; 2023; 13():1008587. PubMed ID: 37007164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphoma.
    Buijs L; Wijermans PW; van Groningen K; Gerrits WB; Kluin P; Haak HL
    Acta Haematol; 1992; 87(3):160-2. PubMed ID: 1379404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
    Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
    Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Castleman's disease associated with myasthenia gravis.
    Day JR; Bew D; Ali M; Dina R; Smith PL
    Ann Thorac Surg; 2003 May; 75(5):1648-50. PubMed ID: 12735602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular dendritic cell tumor of the gastrointestinal tract: Report of a rare neoplasm and literature review.
    Agaimy A; Wünsch PH
    Pathol Res Pract; 2006; 202(7):541-8. PubMed ID: 16564140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the archives of MD Anderson Cancer Center Castleman disease involving the thymus gland: Case report and literature review.
    Rivera D; Wang WJ; Chan KH; Ali H; Wang W; Medeiros LJ; Hu Z
    Ann Diagn Pathol; 2023 Aug; 65():152136. PubMed ID: 37060884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Castleman's disease.
    Shahidi H; Myers JL; Kvale PA
    Mayo Clin Proc; 1995 Oct; 70(10):969-77. PubMed ID: 7564550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunohistological and genotypic study of the plasma cell form of Castleman's disease.
    Hall PA; Donaghy M; Cotter FE; Stansfeld AG; Levison DA
    Histopathology; 1989 Apr; 14(4):333-46; discussion 429-32. PubMed ID: 2737612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.